Form 4: Solid Biosciences Director Ilan Ganot Reports Stock Transactions

Director Ilan Ganot reports the vesting of restricted stock units and subsequent sale of shares to cover withholding taxes.

Summary

• On May 2, 2024, Ilan Ganot, a director of Solid Biosciences Inc., reported transactions involving the company's common stock.
• These transactions included the vesting of 1,553 restricted stock units (RSUs) that converted into common stock.
• Following the vesting, 462 shares were sold at a price of $10.33 to cover withholding taxes.
• After these transactions, Mr. Ganot directly owns 94,807 shares and indirectly owns 19,394 shares through a trust, and 9,507 shares indirectly through his wife.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be informative for investors.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are related to the vesting of RSUs and tax obligations.

Key Dates